Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
In this postmarketing study, the safety of Nonafact® (human coagulation factor IX) is
evaluated in previous treated and untreated patients with severe, moderate or mild
haemophilia B.